WebGilead Sciences Inc. SEC filings breakout by MarketWatch. View the GILD U.S. Securities and Exchange Commission reporting information. WebFind the latest SEC Filings data for Gilead Sciences, Inc. Common Stock (GILD) at Nasdaq.com. Gilead Sciences, Inc. Common Stock (GILD) SEC Filings Nasdaq Skip …
Gilead Sciences Inc (GILD) 10-K Annual Report February 2024
WebApr 14, 2024 · Gilead Sciences (NASDAQ:GILD – Get Rating) had its target price increased by equities researchers at Morgan Stanley from $81.00 to $85.00 in a research report … WebApr 14, 2024 · Gilead Sciences had a return on equity of 44.46% and a net margin of 16.83%. The company had revenue of $7.39 billion for the quarter, compared to analysts’ … fault tolerance vs redundancy
Gilead Sciences, Inc. - Financials - SEC Filings - Nasdaq
WebJul 29, 2024 · Gilead directs readers to its press releases, annual reports on Form 10-K, quarterly reports on Form 10-Q and other subsequent disclosure documents filed with … WebMar 24, 2024 · Ticker: GILD CIK: 882095 Form Type: Proxy Statements Form DEF 14A Accession Number: 0001206774-22-000832 Submitted to the SEC: Thu Mar 24 2024 4:03:54 PM EST Accepted by the SEC: Thu Mar 24 2024 Period: Wednesday, May 4, 2024 Industry: Biological Products No Disgnostic Substances External Resources: Stock … WebMar 2, 2024 · Gilead’s and Forty Seven’s filings with the SEC are also available for free to the public from commercial document-retrieval services and at the website maintained by the SEC at www.sec.gov ... fault-tolerant control systems